Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (121-130 of 297) with videos related to

Pageof 30
Sort By:
Frontiers in Immunology|November 9, 2018
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ FibrosisSwati Bhattacharyya, Wenxia Wang, Zenshiro Tamaki, et al.
Rheumatology (Oxford, England)|October 17, 2024
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung diseaseElana J Bernstein, Francesco Boin, Brett Elicker, et al.
The Journal of Investigative Dermatology|January 11, 2013
p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosisAsish K Ghosh, Swati Bhattacharyya, Robert Lafyatis, et al.
Frontiers in Immunology|February 2, 2024
Perspective to precision medicine in sclerodermaKazuhiro Komura, Koichi Yanaba, Jean-David Bouaziz, et al.
Science Translational Medicine|April 18, 2014
FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signalingSwati Bhattacharyya, Zenshiro Tamaki, Wenxia Wang, et al.
Oncotarget|March 15, 2018
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic targetJun Wei, Roberta G Marangoni, Feng Fang, et al.
Plos One|February 18, 2015
Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional studyJeremy B Katzen, Kirtee Raparia, Rishi Agrawal, et al.
Radiology|February 19, 2011
Nonenhanced MR angiography of the hand with flow-sensitive dephasing-prepared balanced SSFP sequence: initial experience with systemic sclerosisJohn J Sheehan, Zhaoyang Fan, Amir H Davarpanah, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 6, 2009
Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1Guofei Zhou, Laura A Dada, Minghua Wu, et al.
Arthritis Research & Therapy|May 3, 2012
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?Katja Lakota, Jun Wei, Mary Carns, et al.
Pageof 30

Showing results (121-130 of 297) with videos related to

Sort By:
Pageof 30
Frontiers in Immunology|November 9, 2018
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ FibrosisSwati Bhattacharyya, Wenxia Wang, Zenshiro Tamaki, et al.
Rheumatology (Oxford, England)|October 17, 2024
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung diseaseElana J Bernstein, Francesco Boin, Brett Elicker, et al.
The Journal of Investigative Dermatology|January 11, 2013
p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosisAsish K Ghosh, Swati Bhattacharyya, Robert Lafyatis, et al.
Frontiers in Immunology|February 2, 2024
Perspective to precision medicine in sclerodermaKazuhiro Komura, Koichi Yanaba, Jean-David Bouaziz, et al.
Science Translational Medicine|April 18, 2014
FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signalingSwati Bhattacharyya, Zenshiro Tamaki, Wenxia Wang, et al.
Oncotarget|March 15, 2018
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic targetJun Wei, Roberta G Marangoni, Feng Fang, et al.
Plos One|February 18, 2015
Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional studyJeremy B Katzen, Kirtee Raparia, Rishi Agrawal, et al.
Radiology|February 19, 2011
Nonenhanced MR angiography of the hand with flow-sensitive dephasing-prepared balanced SSFP sequence: initial experience with systemic sclerosisJohn J Sheehan, Zhaoyang Fan, Amir H Davarpanah, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 6, 2009
Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1Guofei Zhou, Laura A Dada, Minghua Wu, et al.
Arthritis Research & Therapy|May 3, 2012
Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?Katja Lakota, Jun Wei, Mary Carns, et al.
Pageof 30